Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons

Brain Research

Volumn 889, Issue 1-2, 2001, Pages 138-148

  Tatsuno, Ichiro ^a   Uchida, Daigaku ^a   Tanaka, Tomoaki ^a   Saeki, Naokatsu ^a   Hirai, Aizan ^a   Saito, Yasushi ^a   Moro, Osamu ^b   Tajima, Masahiro ^b  

^a CHIBA UNIVERSITY   (Japan)

^b SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

Cultured rat cortical neuron; Max.d.4; Maxadilan; PAC1 receptor; PACAP; VIP

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MAXADILAN; RECEPTOR SUBTYPE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; BRAIN CELL; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CELLS, CULTURED; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; CYCLIC AMP; INSECT PROTEINS; MOLECULAR SEQUENCE DATA; NEURONS; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASOACTIVE INTESTINAL PEPTIDE; VASODILATOR AGENTS;

EID: 0035910345     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03126-7     Document Type: Article

References (44)

1. Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testes
2. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems
3. Localization and characterization of PACAP receptors in the rat cerebellum during development: Evidence for a stimulatory effect of PACAP on immature cerebellar granule cells
4. Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: A quantitative autoradiographic study
5. Vasoactive intestinal peptide (VIP): Tissue distribution in the rat as measured by radioimmunoassay and by radioreceptorassay
6. Neural cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptides
7. Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone
8. The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth
9. Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts
10. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors
11. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: Characterization and molecular identification
12. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
13. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: Relation to ontogenic events
14. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP)
15. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells
16. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
17. Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis
18. Maxadilan. Cloning and functional expression of the gene encoding this potent vasodilator peptide
19. Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells
20. Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: A possible regulatory mechanism for the local control of energy metabolism
21. Autoradiographic distribution of pituitary adenylate cyclase activating polypeptide (PACAP) binding sites in the rat brain
22. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
23. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)
24. Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity
25. Maxadilan binds to membrane fractions of brain tissue
26. Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist
27. Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist
28. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sypathetic neuroblasts
29. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs
30. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: Actions on the anterior pituitary gland
31. The postnatal development of VIP binding sites in rat forebrain and hindbrain
32. Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain
33. Differential signal transduction by 5 splice variants of the PACAP receptor
34. Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes
35. Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: Molecular identification and interaction with vasoactive intestinal peptide (VIP)
36. Neuropeptide regulation of interleukin-6 production from the pituitary: Stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide
37. Developmental changes of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor in central nervous system (CNS)
38. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide
39. Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway
40. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development
41. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions
42. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway
43. Structural characterization and location of disulphide linkages of a potent vasodilatory peptide, recombinant maxadilan, by a multiple mass spectrometric approach
44. Pituitary adenylate cyclase-activating polypeptide receptors during development: Expression in the rat embryo at primitive streak stage